These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12717)

  • 1. Comparative in vitro studies of cinoxacin, nalidixic acid, and oxolinic acid.
    Gordon RC; Stevens LI; Edmiston CE; Mohan K
    Antimicrob Agents Chemother; 1976 Dec; 10(6):918-20. PubMed ID: 12717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance of Shigellae isolated in Michigan.
    Gordon RC; Thompson TR; Carlson W; Dyke JW; Stevens LI
    JAMA; 1975 Mar; 231(11):1159-61. PubMed ID: 1089819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinoxacin: in vitro antibacterial studies of a new synthetic organic acid.
    Lumish RM; Norden CW
    Antimicrob Agents Chemother; 1975 Feb; 7(2):159-63. PubMed ID: 1094949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial resistance in Shigella flexneri and Shigella sonnei in Hong Kong, 1986 to 1995.
    Chu YW; Houang ET; Lyon DJ; Ling JM; Ng TK; Cheng AF
    Antimicrob Agents Chemother; 1998 Feb; 42(2):440-3. PubMed ID: 9527803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of flumequine against Escherichia coli: in vitro comparison with nalidixic and oxolinic acids.
    Greenwood D
    Antimicrob Agents Chemother; 1978 Mar; 13(3):479-83. PubMed ID: 400825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of six quinolone antibacterials (author's transl)].
    Soussy CJ; Thibault M; Kitzis MD; Acar JF; Duval J; Chabbert YA
    Ann Microbiol (Paris); 1977 Jul; 128B(1):19-33. PubMed ID: 907268
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibacterial activity of cinoxacin in vitro.
    Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1975 May; 7(5):688-92. PubMed ID: 1096811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations.
    Barry AL; Jones RN
    Antimicrob Agents Chemother; 1984 Jun; 25(6):775-7. PubMed ID: 6234858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):146-9. PubMed ID: 984747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of cinoxacin, ampicillin, and chloramphenicol against Shigella and nontyphoid Salmonella.
    Rubinstein E; Shainberg B
    Antimicrob Agents Chemother; 1977 Apr; 11(4):577-9. PubMed ID: 856008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim enhances the antibacterial activity of nalidixic and oxolinic acids and delays the emergence of resistance.
    Bertolini A; Castelli M; Genedani S; Garuti M
    Experientia; 1980 Feb; 36(2):243-4. PubMed ID: 7371772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the prevalence and changing resistance to nalidixic acid and ciprofloxacin of Shigella between Europe-America and Asia-Africa from 1998 to 2009.
    Gu B; Cao Y; Pan S; Zhuang L; Yu R; Peng Z; Qian H; Wei Y; Zhao L; Liu G; Tong M
    Int J Antimicrob Agents; 2012 Jul; 40(1):9-17. PubMed ID: 22483324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):633-7. PubMed ID: 6233935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of oxolinic acid and nalidixic acid against common urinary pathogens: a comparative study.
    de Rautlin de la Roy Y; Toma V; Bobin B
    Curr Med Res Opin; 1978; 5(9):743-8. PubMed ID: 738079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):253-7. PubMed ID: 2941257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of R-factors on the sensitivity of Shigella sonnei to nalidixic acid].
    Sivolodskii EP
    Antibiotiki; 1976 Dec; 21(12):1085-9. PubMed ID: 798548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.